Published on 6 Feb 2022 on Insider Monkey via Yahoo Finance

Was The Smart Money Right About Fate Therapeutics Inc (FATE)?

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the third quarter. You can find articles about an individual hedge fund's trades on numerous financial news websites. However, in this article we will take a look at their collective moves over the last 6 years and analyze what the smart money thinks of Fate Therapeutics Inc (NASDAQ:FATE) based on that data and determine whether they were really smart about the stock.

Is Fate Therapeutics Inc (NASDAQ:FATE) a bargain? Prominent investors were becoming less hopeful. The number of bullish hedge fund bets were trimmed by 4 recently. Fate Therapeutics Inc (NASDAQ:FATE) was in 36 hedge funds' portfolios at the end of September. The all time high for this statistic is 40. Our calculations also showed that FATE isn't among the 30 most popular stocks among hedge funds (click for Q3 rankings). There were 40 hedge funds in our database with FATE positions at the end of the second quarter.

At Insider Monkey, we scour multiple sources to uncover the next great investment idea. For example, lithium prices have more than doubled over the past year, so we go through lists like the 10 best EV stocks to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. Now we're going to review the latest hedge fund action regarding Fate Therapeutics Inc (NASDAQ:FATE).